Suzhou Newma Partners with Kess AI to Establish the 'Small Animal Magnetic Resonance Imaging Center'

In order to jointly expand and strengthen the MRI market in the field of experimental animal disease models and better serve life science research institutions, Suzhou NewMag and Case A BioTech Co., Ltd. have formed a powerful partnership to establish the “Suzhou NewMag · Case A Small Animal MRI Imaging Center.” Mr. Yang Peiqiang, General Manager of Suzhou NewMag, and Mr. Zhuang Yongjie, General Manager of Case A, both attended the grand signing ceremony held this afternoon.

(Left) Mr. Yang Peiqiang, (Right) Mr. Zhuang Yongjie

Case A BioTech (Suzhou) Co., Ltd.

Case A BioTech (Suzhou) Co., Ltd. is a professional contract research organization (CRO) focused on pharmacodynamics, imaging evaluation, pharmacokinetics, non-GLP toxicology evaluation services, and pathology services. The company covers over 100 different disease models in multiple fields, including cardiovascular diseases, autoimmune diseases, inflammatory diseases, metabolic disorders, urological diseases, neurological diseases, and oncology.

Suzhou NewMag Analysis Instruments Co., Ltd.

 

Suzhou NewMag Analysis Instruments Co., Ltd. is a high-tech enterprise specializing in the development and application of low-field nuclear magnetic resonance (NMR) technology. Its business spans across scientific research applications, intelligent equipment, industrial NMR, industry applications, testing services, and K12 inquiry-based education, among many other fields. Currently, NewMag’s products are widely used in agriculture, food, energy exploration, polymer materials, textile industry, life sciences, and more. After more than a decade of development, NewMag has become a leading domestic brand in the field of low-field NMR.

Attendees (Case A BioTech)

 

The attendees from Case A BioTech included: Mr. Zhuang Yongjie, Chairman and General Manager of Case A BioTech Co., Ltd., along with his key management team. Dr. Zhuang Yongjie earned his PhD in Human Pathology and Experimental Cardiovascular Pathology from Akita University, Japan, in 1992. With over 30 years of experience in preclinical pharmaceutical research and development, he is a senior expert in the pharmaceutical R&D field.

Attendees (Suzhou NewMag)

 

Suzhou NewMag was represented at the ceremony by: Mr. Yang Peiqiang, Chairman and General Manager of Suzhou NewMag Analysis Instruments Co., Ltd., a pioneer in the development of NMR technology for nearly 16 years and a “Thousand Talents Program” talent recognized by the Organization Department of the Communist Party of China. Also attending the ceremony were Professor Yan Jun, Director of the Postdoctoral Workstation, Ms. Yang Tingqiao, Deputy Secretary-General of the Precision Medicine Branch, and Mr. Wang Dayu, Product Expert from NewMag’s Artificial Intelligence Division.

The establishment of the small animal MRI imaging platform marks a broader application and service of MRI in vivo detection within the field of experimental animal disease models.

Small Animal MRI Application Areas

 

Diagnosis of neurological disorders in small animals, including tumors, infarctions, hemorrhages, etc.;
Examination of heart disease, lung tumors, large blood vessels in the heart, and mediastinal masses in animals;
CT scans of nasal cavity, sinuses, throat, and other areas;
Diagnosis of bone, joint, and muscle disorders in animals;
Diseases of soft tissue organs such as the uterus, ovaries, bladder, prostate, kidneys, and ureters in animals.